| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $208,376,100 | 74 | 100 |
| Epstein David R | director | 0 | $0 | 7 | $131,637 | $-131,637 |
| Frederick Wayne A.I. | director | 0 | $0 | 1 | $283,820 | $-283,820 |
| West Nadja | director | 0 | $0 | 2 | $368,700 | $-368,700 |
| Doudna Jennifer A | director | 0 | $0 | 5 | $455,224 | $-455,224 |
| Phelps Erik | EVP & Chief Admin & Legal Off | 0 | $0 | 3 | $881,800 | $-881,800 |
| Bartolucci Ryan M | Chief Accounting Officer | 0 | $0 | 5 | $1.31M | $-1.31M |
| Schoenherr Thomas Edward | CEO, Diagnostics | 0 | $0 | 5 | $2.06M | $-2.06M |
| Polovin Andrew | EVP and General Counsel | 0 | $0 | 9 | $5.03M | $-5.03M |
| Rogers James William | Chief Financial Officer | 0 | $0 | 8 | $6.92M | $-6.92M |
| Fukushima Ryan | Chief Operating Officer | 0 | $0 | 14 | $12.6M | $-12.6M |
| LEFKOFSKY ERIC P | CEO and Chairman | 0 | $0 | 17 | $178.81M | $-178.81M |
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life …
Over the last 12 months, insiders at Tempus AI, Inc. have bought $0 and sold $208.38M worth of Tempus AI, Inc. stock.
On average, over the past 5 years, insiders at Tempus AI, Inc. have bought $0 and sold $185.94M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-10-27 | Sale | LEFKOFSKY ERIC P | CEO and Chairman | 250,000 0.1376% | $70.36 | $17.59M | +7.83% | |
| 2026-09-25 | Sale | Schoenherr Thomas Edward | CEO, Diagnostics | 10,281 0.0057% | $85.00 | $873,885 | -16.33% | |
| 2026-09-22 | Sale | LEFKOFSKY ERIC P | CEO and Chairman | 250,000 0.142% | $77.47 | $19.37M | -6.64% | |
| 2026-09-17 | Sale | LEFKOFSKY ERIC P | CEO and Chairman | 200,000 0.1145% | $80.57 | $16.11M | -10.13% | |
| 2026-09-17 | Sale | Polovin Andrew | EVP, Chief Legal Officer | 2,951 0.0016% | $75.00 | $221,325 | -10.13% | |
| 2026-09-17 | Sale | Bartolucci Ryan M | Chief Accounting Officer | 7,062 0.0038% | $75.00 | $529,650 | -10.13% | |
| 2026-09-16 | Sale | Fukushima Ryan | CEO, Data | 700 0.0004% | $70.00 | $49,000 | +6.27% | |
| 2026-09-01 | Sale | Epstein David R | director | 250 0.0002% | $65.55 | $16,388 | +13.44% | |
| 2026-09-01 | Sale | Doudna Jennifer A | director | 676 0.0004% | $65.55 | $44,312 | +13.44% | |
| 2026-09-01 | Sale | Fukushima Ryan | CEO, Data | 30,846 0.0177% | $62.71 | $1.93M | +13.44% | |
| 2026-08-28 | Sale | West Nadja | director | 3,000 0.0018% | $69.00 | $207,000 | +9.56% | |
| 2026-08-25 | Sale | LEFKOFSKY ERIC P | CEO and Chairman | 250,000 0.1421% | $68.46 | $17.11M | +1.80% | |
| 2026-08-21 | Sale | Schoenherr Thomas Edward | CEO, Diagnostics | 2,694 0.0014% | $70.00 | $188,580 | -4.69% | |
| 2026-08-21 | Sale | Fukushima Ryan | CEO, Data | 14,286 0.0076% | $70.00 | $1M | -4.69% | |
| 2026-08-19 | Sale | Polovin Andrew | EVP, Chief Legal Officer | 7,927 0.0041% | $56.00 | $443,912 | +13.11% | |
| 2026-08-19 | Sale | Rogers James William | Chief Financial Officer | 26,313 0.0147% | $60.00 | $1.58M | +13.11% | |
| 2026-08-19 | Sale | Schoenherr Thomas Edward | CEO, Diagnostics | 8,082 0.0044% | $58.40 | $471,991 | +13.11% | |
| 2026-08-18 | Sale | LEFKOFSKY ERIC P | CEO and Chairman | 132,591 0.0761% | $49.61 | $6.58M | +39.92% | |
| 2026-08-18 | Sale | Fukushima Ryan | CEO, Data | 41,095 0.0236% | $49.61 | $2.04M | +39.92% | |
| 2026-08-18 | Sale | Polovin Andrew | EVP, Chief Legal Officer | 22,148 0.0127% | $49.61 | $1.1M | +39.92% |
| Increased Positions | 282 | +58.39% | 20M | +20.93% |
| Decreased Positions | 213 | -44.1% | 13M | -13.83% |
| New Positions | 109 | New | 10M | New |
| Sold Out Positions | 87 | Sold Out | 2M | Sold Out |
| Total Postitions | 552 | +14.29% | 101M | +7.09% |